Premphase - 0046-2575-12 - (conjugated estrogens and medroxyprogesterone acetate)

Alphabetical Index


Drug Information of Premphase

Product NDC: 0046-2575
Proprietary Name: Premphase
Non Proprietary Name: conjugated estrogens and medroxyprogesterone acetate
Active Ingredient(s):    & nbsp;   conjugated estrogens and medroxyprogesterone acetate
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Premphase

Product NDC: 0046-2575
Labeler Name: Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020527
Marketing Category: NDA
Start Marketing Date: 20130301

Package Information of Premphase

Package NDC: 0046-2575-12
Package Description: 1 BLISTER PACK in 1 CARTON (0046-2575-12) > 1 KIT in 1 BLISTER PACK

NDC Information of Premphase

NDC Code 0046-2575-12
Proprietary Name Premphase
Package Description 1 BLISTER PACK in 1 CARTON (0046-2575-12) > 1 KIT in 1 BLISTER PACK
Product NDC 0046-2575
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name conjugated estrogens and medroxyprogesterone acetate
Dosage Form Name KIT
Route Name
Start Marketing Date 20130301
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Premphase


General Information